Drug shortage
Oxybutynin Chloride Tablet · Upsher-Smith Laboratories, LLC
FDA drug shortage · To Be Discontinued · updated May 14, 2025
Key facts
| Generic name | Oxybutynin Chloride Tablet |
|---|---|
| Company | Upsher-Smith Laboratories, LLC |
| Presentation | Oxybutynin Chloride, Tablet, 5 mg (NDC 0832-0038-01) |
| Dosage form | Tablet |
| Status | To Be Discontinued |
| Therapeutic category | Renal |
| Package NDCs | 0832-0038-01 |
| First posted | May 14, 2025 |
| Last updated | May 14, 2025 |
| Discontinued | May 14, 2025 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: